Drugs / PC7
Trials 0
Also used as a comparator or background therapy in 2 trials
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT00381615 Background | Sep 2006 → Jul 2007 | — | Novartis Vaccines | Completed | No outcome recorded |
| Phase 2 | NCT00310856 Background | Jun 2005 → Nov 2006 | meningococcal meningitis | Novartis Vaccines | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | PC7 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00310856 ↗ |
| Modality | Vaccine | “Subjects also received routine vaccines: 2 doses of PC7 (1 dose at 6 and 12 months of age)” NCT00310856 ↗ |
| Route | Intramuscular | “administered by IM injection into the anterolateral area of the left thigh” NCT00310856 ↗ |